NEW YORK – Pacific Biosciences said Monday that it is collaborating with Thailand's Chulalongkorn University on whole-genome sequencing-based newborn screening.
Researchers at Chulalongkorn University will use PacBio's long-read sequencing to evaluate how genomic data can support earlier, more accurate identification of rare and treatable conditions in newborns.
"This marks the first initiative in Asia-Pacific to explore the use of PacBio's HiFi sequencing technology at population scale," the firm said in a statement.
Financial and other details were not disclosed.
"Our shared goal is to establish a robust and scalable research model for genomic newborn screening that helps uncover the genetic basis of undiagnosed conditions from birth," Chulalongkorn University professor Vorasuk Shotelersuk said in a statement.
The collaboration joins a plethora of international, sequencing-based, newborn screening initiatives.